Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors - I
- PMID: 27072805
- PMCID: PMC4913461
- DOI: 10.1016/j.ygyno.2016.04.006
Health-related quality of life in ovarian cancer survivors: Results from the American Cancer Society's Study of Cancer Survivors - I
Abstract
Objective: There are limited data on outcomes and predictors of health-related quality of life (HRQOL) of ovarian cancer survivors. Therefore, we examined the trajectory and predictors of HRQOL one- and two-years post-diagnosis in this population.
Methods: 365 ovarian cancer survivors, a subset of participants in the longitudinal American Cancer Society's Study of Cancer Survivors-I, completed questionnaires at one-year post-diagnosis on sociodemographics, clinical factors, and HRQOL (SF-36). 284 women had HRQOL data at two-years post-diagnosis. In this secondary data analysis, we examined HRQOL at both time points, changes in HRQOL and predictors of HRQOL with univariate and multivariate linear regression.
Results: Mean mental and physical HRQOL scores one-year post-diagnosis were 49.37 (SD±11.59) and 45.96 (SD±10.89), respectively. Older age, lower income, higher disease stage, more comorbidities and greater symptom burden were associated with poorer physical functioning one year post-diagnosis. Younger age, higher stage, having an existing mental health issue, greater symptom burden, and not receiving chemotherapy were associated with poorer mental functioning. Disease recurrence between one- and two-years post-diagnosis and greater symptom burden were predictors of declining physical functioning from one- to two-years post-diagnosis. Mental functioning did not change significantly between assessments.
Conclusions: Overall mental and physical functioning of these ovarian cancer survivors was similar to the general population. However, lower HRQOL was associated with a number of variables, including disease recurrence, treatment status, symptom burden, age, and number of comorbidities. These findings can help health care providers identify survivors who may benefit from relevant interventions.
Keywords: Ovarian cancer; Quality of life; Survivors.
Copyright © 2016 Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Similar articles
-
Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: a longitudinal analysis.Acta Oncol. 2019 May;58(5):790-800. doi: 10.1080/0284186X.2018.1560498. Epub 2019 Jan 30. Acta Oncol. 2019. PMID: 30698069 Clinical Trial.
-
Older ovarian cancer survivors report lower long-term health-related quality of life than younger survivors: A study from the population-based profiles registry.Gynecol Oncol. 2019 May;153(2):391-398. doi: 10.1016/j.ygyno.2019.02.001. Epub 2019 Feb 14. Gynecol Oncol. 2019. PMID: 30772033
-
Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries.BMC Med. 2017 Jan 13;15(1):10. doi: 10.1186/s12916-016-0768-2. BMC Med. 2017. PMID: 28081724 Free PMC article.
-
Candidate Predictors of Health-Related Quality of Life of Colorectal Cancer Survivors: A Systematic Review.Oncologist. 2016 Apr;21(4):433-52. doi: 10.1634/theoncologist.2015-0258. Epub 2016 Feb 24. Oncologist. 2016. PMID: 26911406 Free PMC article.
-
Symptom impact and health-related quality of life (HRQoL) assessment by cancer stage: a narrative literature review.BMC Cancer. 2024 Jul 22;24(1):884. doi: 10.1186/s12885-024-12612-z. BMC Cancer. 2024. PMID: 39039461 Free PMC article. Review.
Cited by
-
Emerging serine-threonine kinase inhibitors for treating ovarian cancer.Expert Opin Emerg Drugs. 2019 Dec;24(4):239-253. doi: 10.1080/14728214.2019.1696773. Expert Opin Emerg Drugs. 2019. PMID: 31755325 Free PMC article.
-
"Lower abdominal pains, as if I was being squeezed…in a clamp": A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer.Patient. 2020 Apr;13(2):189-200. doi: 10.1007/s40271-019-00393-8. Patient. 2020. PMID: 31691205 Free PMC article.
-
Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic.J Psychosoc Oncol. 2024;42(3):299-314. doi: 10.1080/07347332.2023.2244474. Epub 2023 Aug 17. J Psychosoc Oncol. 2024. PMID: 37587850 Free PMC article.
-
Development and Evaluation of an Accelerometer-Based Protocol for Measuring Physical Activity Levels in Cancer Survivors: Development and Usability Study.JMIR Mhealth Uhealth. 2020 Sep 24;8(9):e18491. doi: 10.2196/18491. JMIR Mhealth Uhealth. 2020. PMID: 32969828 Free PMC article.
-
Survivorship research in advanced gynecological cancer: A scoping review of cohort studies.Cancer Med. 2023 Dec;12(24):21779-21797. doi: 10.1002/cam4.6744. Epub 2023 Nov 27. Cancer Med. 2023. PMID: 38009995 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. - PubMed
-
- Khanna D, Tsevat J. Health-related quality of life--an introduction. Am J Manag Care. 2007;13(Suppl 9):S218–23. - PubMed
-
- Greimel E, Daghofer F, Petru E. Prospective assessment of quality of life in long-term ovarian cancer survivors. Int J Cancer. 2011;128(12):3005–11. - PubMed
-
- von Gruenigen VE, et al. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol. 2006;103(1):120–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical